PAVmed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	19.64	39.74	77.26	17.26	6.22	8.22	1.54	0.59	0.77
Cash & Cash Equivalents	19.64	39.74	77.26	17.26	6.22	8.22	1.54	0.59	0.77
Cash Growth	-50.59%	-48.56%	347.72%	177.47%	-24.36%	435.64%	162.09%	-23.67%	-
Receivables	0.06	0.02	0.2	0	0	0	0	0	0
Inventory	0.28	0.11	0	0	0	0	0	0	0
Other Current Assets	4.52	4.05	5.18	1.69	0.33	0.24	0.09	0.16	0.01
Total Current Assets	24.5	43.93	82.64	18.94	6.55	8.46	1.62	0.74	0.78
Property, Plant & Equipment	6.05	5.49	1.59	0.08	0	0	0.02	0.02	0
Goodwill and Intangibles	1.42	3.45	2.03	0	0	0	0	0	0
Other Long-Term Assets	1.15	1.12	0.73	0.76	0.69	0.04	0	0.11	0.44
Total Long-Term Assets	8.62	10.05	4.34	0.84	0.69	0.04	0.02	0.13	0.44
Total Assets	33.12	53.98	86.98	19.78	7.24	8.5	1.64	0.87	1.21
Accounts Payable	1.79	2.7	3.3	2.97	2.35	1.74	0.86	0.95	0.17
Current Debt	45.77	34.79	0	14.96	8.14	7.9	0	0	0
Other Current Liabilities	6.63	3.71	4.26	2.33	1.39	1.33	1.68	0.24	0.41
Total Current Liabilities	54.18	41.2	7.56	20.25	11.88	10.97	2.54	1.19	0.58
Long-Term Debt	2.96	1.85	0	0	0	0	1.94	0	0
Total Long-Term Liabilities	2.96	1.85	0	0	0	0	1.94	0	0
Total Liabilities	57.14	43.05	7.56	20.25	11.88	10.97	4.49	1.19	0.58
Total Debt	48.73	36.64	0	14.96	8.14	7.9	1.94	0	0
Debt Growth	32.99%	-	-	83.81%	2.99%	306.48%	-	-	-
Retained Earnings	-294.43	-228.17	-138.91	-88.28	-53.72	-36.99	-17.91	-7.7	-2.05
Shareholders' Equity	-53.83	-9.68	61.67	1.9	-3.82	-2.31	-2.85	-0.32	0.63
Net Cash / Debt	-29.09	3.11	77.26	2.3	-1.92	0.32	-0.41	0.59	0.77
Net Cash / Debt Growth	-	-95.98%	3264.90%	-	-	-	-	-23.67%	-
Net Cash Per Share	-4.02	0.52	14.95	0.73	-0.95	0.21	-0.45	0.68	1.02
Working Capital	-29.68	2.73	75.08	-1.31	-5.33	-2.51	-0.92	-0.45	0.2
Book Value Per Share	-7.44	-1.63	11.93	0.60	-1.90	-1.56	-3.17	-0.37	0.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).